A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
Portfolio Pulse from Benzinga Insights
Financial analysis reveals a bearish sentiment in the options market for Bristol-Myers Squibb (NYSE:BMY), with 75% of trades showing bearish tendencies. The analysis of unusual trades indicates a targeted price range of $43.0 to $55.0. Significant options trades include both puts and calls, with a notable volume and open interest within this price range. Bristol-Myers Squibb, a leader in immuno-oncology, shows a 1.38% increase in stock price to $48.97, with an upcoming earnings release in 6 days. Analysts, including one from Wells Fargo, set an average target price of $52.0.
April 19, 2024 | 7:16 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bearish options market sentiment with a significant volume of trades targeting a $43-$55 price range. Stock price currently at $48.97, with an anticipated earnings release. Analysts have set a target price of $52.
The bearish sentiment in the options market, combined with the current stock price increase and the upcoming earnings release, suggests a cautious but potentially stable short-term outlook for BMY. The analyst target price of $52 indicates a positive view, balancing the bearish options sentiment.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100